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Abstract
Polymorphisms identified in genome-wide association studies of human traits rarely explain more than a small proportion
of the heritable variation, and improving this situation within the current paradigm appears daunting. Given a well-validated
dynamic model of a complex physiological trait, a substantial part of the underlying genetic variation must manifest as
variation in model parameters. These parameters are themselves phenotypic traits. By linking whole-cell phenotypic
variation to genetic variation in a computational model of a single heart cell, incorporating genotype-to-parameter maps,
we show that genome-wide association studies on parameters reveal much more genetic variation than when using higher-
level cellular phenotypes. The results suggest that letting such studies be guided by computational physiology may
facilitate a causal understanding of the genotype-to-phenotype map of complex traits, with strong implications for the
development of phenomics technology.
Citation: Wang Y, Gjuvsland AB, Vik JO, Smith NP, Hunter PJ, et al. (2012) Parameters in Dynamic Models of Complex Traits are Containers of Missing
Heritability. PLoS Comput Biol 8(4): e1002459. doi:10.1371/journal.pcbi.1002459
Editor: Frederick P. Roth, Harvard Medical School, United States of America
Received September 12, 2011; Accepted February 19, 2012; Published April 5, 2012
Copyright:  2012 Wang et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by the Research Council of Norway (http://www.forskningsradet.no/) under the eVITA program, project number 178901/V30
and by the Virtual Physiological Rat Project funded through NIH grant P50-GM094503. NOTUR, the Norwegian metacenter for computational science, provided
computing resources under project nn4653k. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the
manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: stig.omholt@umb.no
Introduction
The phenotypic variance cumulatively explained by marker loci
found to associate with complex traits in genome-wide association
studies (GWAS) is usually much less than the narrow-sense
heritability [1–6], the ratio of additive genetic variance to total
phenotypic variance. Several explanations have been proposed for
this unexplained variance, popularly called the missing heritability
[1], including imprecise heritability estimates; insufficient sample
size; exclusion of particular types of polymorphisms such as copy
number variants and rare SNPs in GWAS; unaccounted epistatic
effects; and underestimated effect size of associated SNPs due to
incomplete linkage with causal variants [3,6]. Recently it was
shown [7] that a large proportion of the missing heritability can be
accounted for if one estimates the variance explained by all
available marker loci together. This suggests that most of the
genetic variation underlying complex trait variation is due to
marginal effects of many loci that are too small to pass stringent
significance tests. Strong support for this interpretation comes
from several meta-analyses of genome-wide association data [8–
10]. While this insight appears to resolve much of the missing
heritability issue as such, it also implies that standard GWAS
approaches will not be very helpful for disclosing which genetic
variants do actually contribute to additive variance.
Part of the problem underlying the missing heritability is that
while the genotype-phenotype map in reality arises from complex
biological systems best described by nonlinear dynamic models,
the statistical machinery of quantitative genetics, including GWAS
methods, is built upon linear models of gene action. The aim of
this study is not to improve the statistical methods per se, but rather
to explore how more of the missing heritability can be explained
and understood by combining nonlinear dynamic models with
existing GWAS methods. The research program of linking system
dynamics and genetics was suggested more than 40 years ago [11]
and has been an active research area for more than 10 years [12–
24]. Emergent properties of nonlinear systems, such as systemic
silencing [25], might lead to a situation where genetic variation
that penetrates to low-level phenotypes underlying a higher-level
phenotype does not necessarily manifest in the higher-level
phenotype itself. Doing GWAS on these low-phenotypes may
thus reveal more of the genetic variation influencing the higher-
level trait. This line of reasoning is reflected in recent GWA studies
on metabolite profiles [26,27], in pathway and network-based
analysis of genome-wide association studies [28] and in GWAS
analyses on global gene expression data [29–30]. While all these
studies represent important contributions, they do not combine a
genetic mapping framework with mathematical models describing
how high-level trait variation emerges from low-level trait
variation, i.e. they do not provide a quantitative framework for
elucidating how genetic variation affecting a low-level phenotype
do actually influence a focal high-level phenotype.
If a dynamic model can describe the phenotypic variation of a
given trait, it follows that irrespective of the biological resolution of
the model, the genetic variation underlying the phenotypic
variation will have to be reflected as variation in the parameters
of the model. We therefore hypothesized that performing GWAS
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much more of the underlying genetic variation, as well as shedding
light on how this variation actually causes phenotypic variation.
To test the plausibility of this reasoning, we combined GWAS
methodology with a causally-cohesive genotype-phenotype (cGP)
model linking genetic variation to phenotypic variation. More
specifically, a cGP model [19] is a mathematical model of a
biological system where low-level parameters have an articulated
relationship to an individual’s genotype, and higher-level pheno-
types emerge from the mathematical model describing the causal
dynamic relationships between these lower-level processes. Our
approach bears some resemblance to that of functional GWAS
(fGWAS) [31], where the genetic control of traits is analyzed by
integrating biological principles of trait formation into the GWAS
framework through mathematical and statistical bridges. Fu et al.
[23] recently extended the functional mapping framework [15] to
handle cyclic phenotypes such as circadian rhythms by combining
differential equations with functional mapping of QTLs. However,
there are clear differences between functional mapping and the
cGP approach. In functional mapping the phenotypic measure-
ments are currently done at the systems level, while lower-level
parameters are estimated by combining curve-fitting with more
classical QTL methods. In contrast, the cGP approach advocated
here focuses on measuring lower-level parameters based on the
idea that they are highly relevant phenotypes of the system.
We studied a cGP model of a mouse heart cell [24], where
genetic variation is mapped to parametric variation, which
propagates through the physiological model to generate multivar-
iate phenotypes for the action potential (an electrical signal) and
calcium transient (linked to muscle contraction) under regular
pacing. The rationale for using a heart cell model was that
multiscale and multiphysics modelling of the mammalian heart has
a solid empirical basis, and arguably comprises the most complex
mathematical conceptualization of any organ or physiological trait
available. For clarity of exposition, and because heart cell models
lie at the core of this class of multiscale whole organ models [32–
37], we deemed it sufficient to illustrate our points using a single
cell model only. We used HapMap data [38,39] as a guide to
generate genetic variation with realistic allele frequencies and
linkage disequilibrium to underlie variation in the model
parameters. Based on HapMap [39] individuals we simulated
complex pedigree populations and performed GWAS on both low-
level parameters and high-level phenotypes arising from the cGP
model. The layout of the computational pipeline used for this
study is depicted in Figure 1.
We show that genome-wide association studies on parameters
reveal many more of the underlying SNPs than when using higher-
level cellular phenotypes. Furthermore, the SNPs identified by
GWAS on parameters can be used to build multivariate prediction
models of higher-level phenotypes giving much higher explained
variance than from GWAS on higher-level phenotypes alone. Our
results suggest that combining statistical genetics with computa-
tional biology will facilitate both identification of genetic variation
underlying complex traits and a much deeper understanding of
how this genetic variation becomes causative.
Methods
The general layout of the study is outlined in Figure 1.
Heart cell model
The cell model [40] extends that of Bondarenko et al. [41] with
more realistic calcium handling, conservation of charge, and
detailed re-parameterization to consistent experimental data for
the C57BL/6 ‘‘black 6’’ mouse. State variables include ion
concentrations of sodium, potassium and calcium in the cytosol,
calcium concentration in the sarcoplasmic reticulum, and the state
distribution of ion channels, whose transition rates between open,
closed, and inactivated conformations may depend on transmem-
brane voltage. Formulated as a system of coupled ordinary
Figure 1. Flowchart of computational pipeline. A heart cell
model, a genetic map and a virtual population are tied together by
selecting heart model parameters assumed to be under influence of
genetic variation and associating the parameter variation to a
population of virtual genomes based upon HapMap 3 data. Individual
genotypes are mapped into heart model parameters (steps 1–3) and by
running the heart cell model parameters are mapped into cell-level
phenotypes (step 4). Finally, GWAS analysis is then performed on the
virtual population (step 5).
doi:10.1371/journal.pcbi.1002459.g001
Author Summary
Despite an ever-increasing number of genome locations
reported to be associated with complex human diseases or
quantitative traits, only a small proportion of phenotypic
variations in a typical quantitative trait can be explained by
the discovered variants. We argue that this problem can
partly be resolved by combining the statistical methods of
quantitative genetics with computational biology. We
demonstrate this for the in silico genotype-to-phenotype
map of a model heart cell in conjunction with publically
accessible genomic data. We show that genome wide
association studies (GWAS) on model parameters identify
more causal variants and can build better prediction
models for the higher-level phenotypes than by perform-
ing GWAS on the higher-level phenotypes themselves.
Since model parameters are in principle measurable
physiological phenotypes, our findings suggest that
development of future phenotyping technologies could
be guided by mathematical models of the biological
systems being targeted.
Dynamic Model Parameters and Missing Heritability
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representation of membrane-bound channels and transporter
functions as well as fluxes between the cytosol and intracellular
organelles. As the action potential and calcium transient features
following an electrical stimulation are the only state descriptors fed
into higher level features of current multiscale heart models [33],
we used these and associated aggregated measures as high-level
phenotypes, see ‘‘Parameter to phenotype mapping’’ below. See
Vik et al. [24] for a detailed description of this model including
model diagram, differential equations and a CellML implemen-
tation.
Polymorphic parameters
Out of the 86 model parameters we chose 34 to mediate the
effects of genetic variation (Table 1 and Table S1). Because the
genotype to parameter map for parameters describing ion channel
properties may in general be much more straightforward than
what is the case for many others, we picked mainly parameters
describing affinities, conductivities and ion permeabilities for the
ion channels and pumps underlying four potassium outward
currents, one calcium current, one chloride current, one sodium
current, the sodium-calcium exchangers, the sarcoplasmic reticu-
lar calcium ATPase (SERCA), the sodium potassium pump,
cytosolic calmodulin, the ryanodine receptors on sarcoplasmic
reticulum and the calcium handling processes within sarcoplasmic
reticulum.
Virtual genome and virtual population
To ensure some realism in the construction of the genetic
structure of our in silico populations in terms of allele frequencies
and LD patterns, we extracted HapMap3 data [39] for 2,000
evenly spaced SNPs (,5000 nucleotides apart) for each of the first
20 autosomal chromosomes. We extracted genotypes for the
40000 SNPs for the 1301 individuals in the 11 HapMap 3
populations. We then expanded this into a population of 5000
individuals by use of the Python package simuPOP [42]. The
population expansion by simuPOP maintained allele frequencies
and LD patterns in accordance with the HapMap 3 data.
Mutations were introduced based on a symmetric diallelic
mutation model, all recombinations were based on genetic maps
estimated from the HapMap data and migrations between the 11
subpopulations were allowed for. The mutation rate, migration
rate and number of generations used as input to the simuPOP
population expansion were 1e-8, 0.001 and 500, respectively.
Genotype to parameter mapping
Assuming a purely additive genetic model, 400 causal SNPs
were randomly sampled from the virtual genome for each of the
34 parameters selected to mediate genetic variation. The genotype
to parameter mapping for each parameter was set up by defining
the 5,000640,000 genotype matrix G, where each element gij
denoted the genotype of individual i at SNP j (21 for the
homozygous with the least frequent allele, 0 for the heterozygous
and 1 for the homozygous with the most frequent allele). We then
constructed for each parameter the 40,000x1 relative effect vector
E, where element ej was sampled from a Laplace (0, 0.0035)
distribution if the j-th SNP was among the 400 parameter-specific
causative SNPs, and set to 0 otherwise (the relative effect being
defined as the percentage increase or decrease of the baseline
parameter value (Table 1 and Table S1)). The 5000-element
vector of parameter values for all individuals was then computed
as p(GE+1), where p is the baseline value. With this procedure,
each of the focal 34 parameters was varied within ,635% of its
baseline value, and for each causal SNP, the heterozygous
individuals were assigned the baseline parameter value (Table 1
and Table S1). The 635% parameter variation range was chosen
as a compromise between getting ample genetic signals and
avoiding too many physiologically unrealistic phenotypes. We also
tested a genetic model with 200 causative SNPs for each
parameter, the only difference being that the standard deviation
of the Laplace distribution was set to 0.0049.
Parameter to phenotype mapping
Cellular phenotypes for individual parameter sets were
generated by a virtual experiment of constant pacing as described
in Bondarenko et al. [41]. The potassium current was stimulated by
215 V/s for 3 ms at the start of each stimulus interval.
Convergence was checked by comparing successive intervals with
respect to the initial value of each state variable as well as the
integral of its trajectory over that interval. A running history of 10
intervals was kept, and after each interval we checked for a match
(within a relative tolerance of 5% for all state variables) against the
previous one. This was done for three different pacing rates with
stimulus intervals of intervals 100, 200 and 300 ms, respectively.
The cell dynamics was categorized as ‘‘failure’’ if it did not
converge to non-alternating dynamics within 10 minutes of
simulation time. The Python code of the heart cell model was
autogenerated from CellML [43], using the code generating
service available at the CellML repository (www.cellml.org). The
equations were integrated using the CVODE solver [44] with a
Python wrapper.
Eight scalar phenotypes (see Table 2 and Table S2) were
extracted from each computed action potential and calcium
transient curve: the initial value (apbase and ctbase), the amplitude
(apamp and ctamp), the peak value (appeak and ctpeak), the time
to peak value (apttp and ctttp), the time to 25%, 50%, 75%, and
90% of the initial base value (apd25, apd50, apd75, apd90 and
ctd25, ctd50, ctd75, ctd90).
Data preparation
We removed individuals with physiologically unrealistic pheno-
types within each of the 100 datasets analyzed. The exclusion
criterion was based on the inter-quartile range (IQR); points that
were more than twice the IQR above the third quartile or below
the first quartile were excluded. Each filtered data set, containing
4000–5000 individuals, was divided into a training set of 2500
individuals and a test set consisting of the remaining individuals.
The training data set was used to detect causal SNPs, compute the
false positive rate and sensitivity characteristics. The test set was
used to estimate the phenotypic variation accounted for by the
detected SNPs.
Statistical analysis
The same GWAS procedure was used for each parameter and
each phenotype. The quantitative trait association analysis was
performed with the program PLINK [45] on the training data. We
used a threshold of 1e-5 on the Bonferroni-corrected p-value from
PLINK to determine the set of significant SNPs.
The detected SNP set and associated discovery rates were
defined as follows. Let Si denote the set of significant SNPs from
GWAS on the i-th parameter and let Ci denote the causal SNPs set
of the i-th parameter. The set of detected SNPs of the i-th
parameter was then computed as Di=Si>Ci, and the discovery
rate of i-th parameter was computed as di=|Di|/|Ci|. The union
of causal SNP sets for parameters defined the causal SNP set
underlying all cellular phenotypes, and the detected SNP set and
the discovery rate for each cellular phenotype was computed in the
Dynamic Model Parameters and Missing Heritability
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the i-th parameter or phenotype, Fi, consists of SNPs in the set of
significant SNPs Si that are not in the causal SNPs set Ci.. The
false positive rate of the i-th parameter or phenotype was defined
as the number of false positive SNPs in Fi divided by the number
of signals in Si,| Fi|/|Si|.
To quantify explained genetic variance a multiple regression
model was constructed by regressing the phenotype or parameter
value of the training set on the causal SNPs detected by GWAS
(similar to the weighted genomic profile approach in [46]). Then
the phenotypes of test set individuals were predicted using the
corresponding fitted models. We measured the explained variation
by the R
2 values from regressing observed values on predicted
phenotypic values for the individuals in the test set.
Global sensitivity analysis
We quantified the linear sensitivity [47] of each phenotype to
each parameter using linear regression in the training set. For each
high-level phenotype and Monte Carlo simulation we used the
2500 simulated phenotypes as response and performed a series of
univariate regressions each time with a single parameter as
predictor. We measured global sensitivity by the coefficient of
determination (R
2).
Results/Discussion
The proportion of true causative SNPs detected by GWAS was
as expected substantially higher for the parameters than for the
cellular phenotypes (Figure 2 and Figure S2 for the 200 SNPs
Table 1. Parameters with genetic variation.
Parameter
name Description Unit Baseline value Min Max
Ka+ The PC1 – PO1 rate constant of the Ryanodine receptor mM
24/ms 6.08e-3 4.09e-3 8.06e-3
Ka2 The PO1 – PC1 rate constant of the Ryanodine receptor ms
21 7.133-2 4.70e-2 9.58e-2
Kb+ The PO1 – PO2 rate constant of the Ryanodine receptor mM
23/ms 4.05e-3 2.64e-3 5.47e-3
Kb2 The PO2 – PO1 rate constant of the Ryanodine receptor ms
21 9.65e-1 6.32e-1 1.31
Kc+ The PO1 – PC2 rate constant of the Ryanodine receptor ms
21 9.00e-3 6.09e-3 1.20e-2
Kc2 The PC2 – PO1 rate constant of the Ryanodine receptor ms
21 8.00e-4 5.24e-4 1.07e-3
m The Ca
2+ cooperativity parameter of PO1 – PO2 of the Ryanodine receptor - 3.0 1.99 3.97
n The Ca
2+ cooperativity parameter of PC1 – PO1 of the Ryanodine receptor - 4.0 2.75 5.33
P_CaL The permeability of the L-type Ca
2+ channel ms
21 2.5 1.62 3.30
t_L The time constant of the switch between open and close states of the L-type Ca
2+ channel ms
21 1.5 1.01 1.98
tau_L The Inactivation time constant of the L-type Ca
2+ channel ms
21 1.15e3 7.82e2 1.52e3
phi_L The proportion of closed states in open mode of the L-type Ca
2+ channel - 1.80 1.23 2.43
Kup The SERCA affinity to Ca
2+ mM 4.12e-1 2.93e-1 5.68e-1
V1 The leak constant of the Network Sarcoplasmic Reticulum ms
21 4.5 3.05 5.90
KCSQN The Calsequestrin affinity to Ca
2+ mM 6.30e2 4.35e2 8.57e2
K_Co The affinities of the Na
+/Ca
2+ exchanger to extracellular Ca
2+ mM 1.4e3 9.38e2 1.85e3
K_Ci The affinities of the Na
+/Ca
2+ exchanger to intracellular Ca
2+ mM 3.6 2.45 4.93
K_No The affinities of the Na
+/Ca
2+ exchanger to extracellular Na
+ mM 8.80e4 6.06e4 1.20e5
K_Ni The affinities of the Na
+/Ca
2+ exchanger to intracellular Na
+ mM 1.2e4 8.38e3 1.58e4
KNai The affinity of the Na
+/K
+ pump to intracellular Na
+ mM 1.66e4 1.13e4 2.17e4
KKo The affinity of the Na
+/K
+ pump to extracellular K
+ mM 1.5e3 1.04e3 2.08e3
KpCa The affinity of the Ca
2+ pump to intracellular Ca
2+ mM 2.89e-1 1.95e-1 3.93e-1
Vmax The maximal exchange rate of Na
+/Ca
2+ exchanger pA/pF 3.94 2.71 5.19
Imax The maximal current of the Na
+/K
+ pump pA/pF 2.49 1.71 3.58
GK1 The maximal conductance of the time-dependent K
+ channel ms/mF 3.5e-1 2.39e-1 4.52e-1
GKr The maximal conductance of the rapid delayed rectifier K
+ channel ms/mF 1.65e-2 1.11e-2 2.17e-2
GKur The maximal conductance of the ultrarapidly activating delayed rectifier K
+ channel ms/mF 2.50e-1 1.76e-1 3.27e-1
KCl The half saturation constant of the Ca
2+ activated Cl
2 channel mM 1.00e1 6.65 1.36e1
GNa The maximal conductance of the Na
+ channel ms/mF 1.60e1 1.07e1 2.10e1
GKtof The maximal conductance of the rapidly recovering transient outward K
+ channel ms/mF 5.35e-1 3.97e-1 7.11e-1
GClCa The maximum conductance of the Ca
2+ activated Cl
2 channel ms/mF 1.00e1 6.56 1.33e1
on_rate The autophosphorylation rate of Calmodulin ms
21 5.0e-2 3.25e-2 6.56e-2
off_rate The dephosphorylation rate of the Calmodulin ms
21 2.0e-4 1.34e-4 2.67e-4
IpCm The maximal current of the Ca
2+ pump pA/pF 9.55e-2 6.35e-2 1.26e-1
Listing of the 34 parameters where genetic variation was introduced. The descriptions, units and baseline values are taken from the original publication [40]. The
minimum and maximum values were obtained from the Monte Carlo simulations.
doi:10.1371/journal.pcbi.1002459.t001
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3.5%–4% after GWAS directly on parameter values (Figure 2A),
and this number dropped to ,0.05% for GWAS studies on action
potential phenotypes and ,0.02% for calcium transient pheno-
types (Figure 2B), and the corresponding figures in the 200 SNPs
case were 8–8.5%, ,0.16% and ,0.08%. The low overall
detection rates were to be expected since we sampled SNP effects
from an L-shaped distribution resulting in datasets where a small
proportion of the SNPs underlying a given parameter will explain
a substantial part of the variation. The main explanation for the
decrease in detection rates is that the number of causal SNPs
increases 34 times and the relative effects of all causal SNPs
decrease, making them harder to pick up. Another, probably less
important, phenomenon contributing to lower detection rates at
the higher-level phenotypes is that going from parameter level to
the system-level phenotype introduces nonlinearities in the SNP
effects, and standard GWAS methods pick up only the additive
part.
The difference between parameter and cellular phenotypes is
also evident when looking at the amount of phenotypic variance
explained by SNPs detected in the GWAS (Figure 3 and Figure S3
for the 200 SNPs case). The median explained variance is typically
in the range 30–40% for parameter phenotypes (Figure 3A), 10–
20% for action potential phenotypes and ,5% for calcium
transient phenotypes (Figure 3B). The proportion of phenotypic
variance explained by detected SNPs was on average 2.6 (2.0 in
the 200 SNP case) and 5.6 (3.9 for the 200 SNPs case) times higher
for a parameter phenotype than for an action potential and
calcium transient phenotype, respectively. However, when we
made use of the SNPs detected for parameters we were able to
explain 1.8 and 3.9 times (1.6 and 2.9 times for the 200 SNPs case)
more of the phenotypic variance of the action potential and
calcium transient phenotypes, respectively, approaching the levels
obtained for the parameters (Figure 3C). We also calculated the
explained variances with all significant SNPs and obtained similar
results. This suggests that our approach can be tested empirically
in a straightforward way.
The gain in explained variance by using parameter-associated
SNPs was not as dramatic for the action potential phenotypes as
for the calcium transient phenotypes (Figure 3C), but even in this
case the gain in number of identified SNPs was on average 13.96
(12.3 for the 200 SNPs case). The corresponding figure for the
calcium transient phenotypes was 39.46 (26.5 for the 200 SNPs
case). Because these additional SNPs are attached to one or more
parameters describing specific biological processes or features that
are causally related according to the functional structure of the
mathematical model, the gain in our causal understanding of the
genotype to phenotype map may be substantial.
Both the detection rate of causal SNP and the variances
explained for the calcium transient phenotypes were overall
significantly lower than those for the action potential phenotypes
(Figure 2B and 3B). We investigated this further by a linear global
sensitivity analysis of how variation in the cellular phenotypes
depended on variation in the parameters, and compared this with
the number of causative SNPs for each parameter detected by
performing GWAS on high-level cellular phenotypes. We found
that the GWAS results for the two cellular phenotype groups are
predominantly a consequence of the sensitivity structure of the
dynamic model (Figure 4 and Figure S4 for the 200 SNPs case),
and that the action potential phenotypes are overall more sensitive
to fewer parameters than the calcium transient phenotypes. The
only exception to this latter pattern is the parameter Kup,
quantifying the affinity of SERCA to calcium ions (Figure 4A). It
has a substantial impact on the calcium transient base value
phenotype (ctbase), and the amount of variance explained by the
SNPs detected for this phenotype is on par with the action
potential phenotypes (Figure 3B). This suggests that SNPs
associated with traits that are sensitive to few parameters will
have a higher penetrance than SNPs associated with traits that are
sensitive to many parameters for a given model resolution.
Moreover, the results imply that the more poly-parametric the
sensitivity profile of a model phenotype is, the more will be gained
in terms of added explained variance by performing GWAS on
parameters. On the other hand, the results also imply that a
sensitivity analysis can be used to systematically reveal hotspots for
genetic variation underlying a complex trait and thus guide a
parameter phenotyping program. Within this framework a SNP
affecting a parameter to which the focal higher-level phenotypes
are not very sensitive will have little impact on these phenotypes
unless it is highly penetrant at the parameter level.
GWAS methods are well known for producing false positives
due to multiple testing and high LD between SNPs. A typical
GWAS block of SNPs in high LD is often reduced to a subset of
tagSNPs in low LD (typically with a pairwise correlation ,0.2).
The GWAS methods are aimed at identifying significant tagSNPs,
and the task of distinguishing the causal SNPs from false positives
in high LD has to be done with other methods such as functional
studies of candidate SNPs. Our approach is not intended to solve
this problem (but see e.g. [48,49] for reviews of methods for
identifying causal variants after GWAS) and in our study the
increases detection rate for parameters is accompanied by an
expected increased false positive rate (Figure S1 and Figure S5 for
the 200 SNPs case). However, as parameters as a rule are closer to
mechanism than higher-level phenotypes, it should be noted that
to do GWAS on parameters could become very instrumental for
identifying candidate mechanisms and genes for follow up studies.
We envision that ongoing efforts such as the RICORDO project
[50] aimed at developing semantic interoperability for biomedical
data and models will facilitate bioinformatic identification of
Table 2. Attained cellular phenotype values.
Phenotypes Unit Baseline value Min Max
apd25 ms 4.34 4.10 4.56
apd50 ms 5.89 5.33 6.39
apd75 ms 1.11e1 9.28 1.29e1
apd90 ms 1.95e1 1.60e1 2.30e1
apamp mV 1.18e2 1.14e2 1.23e2
apbase mV 28.00e1 28.0.6e1 27.93e1
appeak mV 3.82e1 3.41e1 4.23e1
apttp ms 3.20 3.03 3.35
ctd25 ms 6.19e1 4.80e1 7.98e1
ctd50 ms 1.05e2 7.98e1 1.37e2
ctd75 ms 1.79e2 1.39e2 2.16e2
ctd90 ms 2.55e2 2.20e2 2.79e2
ctamp mM 1.4e-1 4.85e-2 2.76e-1
ctbase mM 8.14e-2 6.12e-2 1.05e-1
ctpeak mM 0.22 1.15e-1 3.68e-1
ctttp ms 2.40e1 1.93e1 2.98e1
The phenotypic values resulting from use of the baseline parameter values (see
Table 1) are listed together with the minimum and maximum values achieved in
the Monte Carlo simulations.
doi:10.1371/journal.pcbi.1002459.t002
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GWAS results on parameter phenotypes.
We made deliberate use of the simplest possible genotype to
parameter map in this study. A more complex map incorporating
genetic dominance and various types of epistasis [51] would have
diminished the SNP discovery rates and the explained variances of
the parameters. However, this reduction in penetrance would
apply equally well at higher phenotypic levels, and so would not
affect our conclusions. We did not put any environmental
variation on the parameters as we deemed this unnecessary in a
Figure 2. Percentage of causative SNPs detected by GWAS. (A) The percentage of 400 causative SNPs (y axis) detected as significant SNPs by
GWAS on genetically controlled model parameters (x axis). (B) The percentage of all 13600 causative SNPs (y axis) detected as significant SNPs by
GWAS on cellular phenotypes (x axis). Each boxplot summarizes 100 Monte Carlo runs. See Methods for further descriptions of model parameters and
phenotypes.
doi:10.1371/journal.pcbi.1002459.g002
Figure 3. Phenotypic variance explained by genotypic variation. (A) Total explained variance for genetically controlled parameters (x axis)
using detected causal SNPs as predictors. (B) Total explained variance for cellular phenotypes (x axis) using detected causal SNPs obtained from
GWAS targeting these phenotypes. (C) Total explained variance for cellular phenotypes (x axis) using detected causal SNPs obtained from GWAS
targeting all genetically controlled parameters. Each boxplot summarizes total explained variance by GWAS for 100 Monte Carlo runs. Explained
variance was measured as R
2 from test set prediction with a multiple regression model, see Methods for further descriptions.
doi:10.1371/journal.pcbi.1002459.g003
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strength at the parameter and cellular phenotype levels. However,
in future studies this aspect needs to be taken into account in order
to make quantitative assessments of how well we will be able to
pick up genetic signals as function of environmental variation.
Our approach will remain useful in conjunction with future
advances in statistical GWAS methodology, as it is applicable to
any phenotypic variation that can be described by computational
physiological modeling, irrespective of its position in the
phenotypic hierarchy. Even in those cases where the parameters
of a computational model are quite high-level phenotypes, our
results suggest that one will be able to gain insights about the
genotype to phenotype map that would otherwise be challenging
to achieve.
There has been an enormous expansion in efforts to model
complex biological systems the last decade, and steadily expanding
model repositories such as http://www.cellml.org and http://
biomodels.net facilitate exchange and reuse of such models.
Illustratively, our study benefited from the reuse of a model
available in CellML format. Future development of the cGP
approach and systems genetics in general will benefit greatly from
these standards and online resources as well as modeling efforts
like the Virtual Physiological Human (http://www.vph-noe.eu).
Reflecting upon how to improve the current performance of
large-scale GWA studies aiming to find the genetic determinants
underlying complex diseases, Dermitzakis and Clark stated
recently that ‘‘A major breakthrough will be to predict and
interpret the effect of mutational and biochemical changes in
human cells and understand how this signal is transmitted spatially
(among tissues) and temporally (spanning development)’’ [52]. Our
results suggest that combining GWAS methodology with a mature
phenomics technology guided to fit the needs of computational
physiology [53], may contribute substantially to making this vision
come true.
Supporting Information
Figure S1 False positive rates of GWAS on parameters
and cellular phenotypes (400 SNPs case). Boxplots
summarizing false positive rates (y axis) for 100 Monte Carlo
simulations for (A) parameters and (B) cellular phenotypes. The
false positive rate is defined as the proportion of the non-causative
SNPs among those identified as significant by the GWAS.
(EPS)
Figure S2 Percentage of causative SNPs detected by
GWAS (200 SNPs case). (A) The percentage of 200 causative
SNPs (y axis) detected as significant SNPs by GWAS on genetically
controlled model parameters (x axis). (B) The percentage of all
6800 causative SNPs (y axis) detected as significant SNPs by
GWAS on cellular phenotypes (x axis). Each boxplot summarizes
100 Monte Carlo runs. See Methods for further descriptions of
model parameters and phenotypes.
(EPS)
Figure S3 Phenotypic variance explained by genotypic
variation (200 SNPs case). (A) Total explained variance for
genetically controlled parameters (x axis) using detected causal
SNPs as predictors. (B) Total explained variance for cellular
phenotypes (x axis) using detected causal SNPs obtained from
GWAS targeting these phenotypes. (C) Total explained variance
for cellular phenotypes (x axis) using detected causal SNPs
obtained from GWAS targeting all genetically controlled param-
eters. Each boxplot summarizes total explained variance by
GWAS for 100 Monte Carlo runs. Explained variance was
measured as R
2 from test set prediction with a multiple regression
model, see Methods for further descriptions.
(EPS)
Figure S4 The close resemblance between GWAS results
and linear sensitivity analysis (200 SNPs case). (A) The
number of causative SNPs for each parameter (y axis) detected by
performing GWAS on high-level cellular phenotypes (x axis). The
color intensity of each square describes the mean value of 100
Monte Carlo runs. (B) Sensitivities of the high-level phenotypes (x
axis) of the 2500 individuals in the training set to variation in each
parameter (y axis) quantified by univariate linear regression (see
Methods). The color intensity of each square describes the mean
R
2 (coefficient of determination) value of 100 Monte Carlo runs.
(EPS)
Figure S5 False positive rates of GWAS on parameters
and cellular phenotypes (200 SNPs case). Boxplots
summarizing false positive rates (y axis) for 100 Monte Carlo
simulations for (A) parameters and (B) cellular phenotypes. The
false positive rate is defined as the proportion of the non-causative
SNPs among those identified as significant by the GWAS.
(EPS)
Table S1 Parameters with genetic variation. This sup-
plementary table contains data similar to that shown in Table 1,
the only difference being that it is based on 200 causal SNPs per
parameter instead of 400.
(PDF)
Table S2 Attained cellular phenotype values. This
supplementary table contains data similar to that shown in
Figure 4. The close resemblance between GWAS results and
linear sensitivity analysis. (A) The number of causative SNPs for
each parameter(y axis) detected by performing GWAS on high-level
cellular phenotypes(x axis). The color intensity of each square describes
the mean value of 100 Monte Carlo runs. (B) Sensitivities of the high-
level phenotypes (x axis) of the 2500 individuals in the training set to
variation in each parameter (y axis) quantified by univariate linear
regression (see Methods). The color intensity of each square describes
the mean R
2 (coefficient of determination) value of 100 Monte Carlo
runs.
doi:10.1371/journal.pcbi.1002459.g004
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SNPs per parameter instead of 400.
(PDF)
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